What is aTyr Pharma's revenue?

aTyr Pharma (ATYR) generated $190.0K in revenue over the trailing twelve months, down 19.1% year over year.

Is aTyr Pharma profitable?

aTyr Pharma is not currently profitable: it reported a net loss of $70.0M over the trailing twelve months, a -39009.5% net margin.

What is aTyr Pharma's earnings per share?

aTyr Pharma's diluted EPS over the trailing twelve months is $-0.73.

Where does aTyr Pharma's income statement data come from?

Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

aTyr Pharma ATYR Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	——	$190K-19.1%	$190K-19.1%	$0-100%	$0-100%
Research and development	$55.72M+5.5%	$60.22M+10.8%	$61.56M+12.1%	$54.23M+7.6%	$52.82M+14.1%
General and administrative	$17.76M+24.8%	$17.6M+27.7%	$17.29M+29.1%	$15.82M+24.5%	$14.23M+8.8%
Other operating expenses	$73.48M+9.6%	$77.82M+14.2%	$78.84M+15.5%	$70.05M+11.0%	$67.05M+13.0%
Total operating expenses	$73.48M+9.6%	$77.82M+14.2%	$78.84M+15.5%	$70.05M+11.0%	$67.05M+13.0%
Operating income	-$73.29M-9.3%	-$77.63M-14.3%	-$78.65M-15.6%	-$70.05M-12.0%	-$67.05M-14.1%
Other income (expense), net	$3.26M-10.4%	$3.5M-10.0%	$3.52M-16.8%	$3.41M-26.4%	$3.64M-24.8%
Net income	-$70.03M-10.4%	-$74.12M-15.8%	-$75.12M-17.7%	-$66.64M-15.1%	-$63.41M-17.6%
Diluted earnings per share	-$0.73+8.8%	-$0.79+8.1%	-$0.82+12.8%	-$0.79+13.2%	-$0.80+11.1%
Basic earnings per share	-$0.73+8.8%	-$0.79+8.1%	-$0.82+12.8%	-$0.79+13.2%	-$0.80+11.1%
Weighted-average shares, diluted	378.3M+22.5%	366.7M+27.2%	348M+30.0%	326.7M+30.7%	308.8M+32.7%
Weighted-average shares, basic	378.3M+22.5%	366.7M+27.2%	348M+30.0%	326.7M+30.7%	308.8M+32.7%
EBIT	-$73.29M-9.3%	-$77.63M-14.3%	-$78.65M-15.6%	-$70.05M-12.0%	-$67.05M-14.1%
EBITDA	-$72.63M-9.5%	-$76.96M-14.5%	-$77.98M-15.8%	-$69.36M-12.2%	-$66.35M-14.2%
EBITDA	-$72.63M-9.5%	-$76.96M-14.5%	-$77.98M-15.8%	-$69.36M-12.2%	-$66.35M-14.2%
EBIT	-$73.29M-9.3%	-$77.63M-14.3%	-$78.65M-15.6%	-$70.05M-12.0%	-$67.05M-14.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about aTyr Pharma.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's revenue?: aTyr Pharma (ATYR) generated $190.0K in revenue over the trailing twelve months, down 19.1% year over year.
Is aTyr Pharma profitable?: aTyr Pharma is not currently profitable: it reported a net loss of $70.0M over the trailing twelve months, a -39009.5% net margin.
What is aTyr Pharma's earnings per share?: aTyr Pharma's diluted EPS over the trailing twelve months is $-0.73.
Where does aTyr Pharma's income statement data come from?: Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.